MIPHARM, spol. s r.o.Active
Key figures
Key figures
2025Dividends
calculatedDistributed as dividends 2 820 € (18 % of distributable profit).
Balance sheet structure
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 0 | 0 | 22 500 | 30 000 | 22 500 |
| Profit for the reporting year | 0 | 0 | 11 599 | 18 804 | 18 982 |
| Retained earnings of previous periods | -14 811 | -14 811 | -14 811 | -3 212 | 12 772 |
| Total assets | 8 210 | 8 210 | 29 581 | 42 231 | 40 502 |
| Total liabilities | 16 382 | 16 382 | 26 154 | 20 000 | 2 109 |
| Total equity | -8 172 | -8 172 | 3 427 | 22 231 | 38 393 |
| Calculated dividends | — | 0 | 0 | 0 | 2 820 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Similar companies
Summary: MIPHARM, spol. s r.o.
Overview
MIPHARM, spol. s r.o. (IČO 36718327) is a limited liability company (s.r.o.). The company was incorporated in 2006 and has existed for 19 years. Registered office according to the register: Michalovce. Main activity according to the Statistical Office: sprostredkovateľské služby v oblasti nehnuteľností (SK NACE 6831).
People
The company has one statutory representative. According to the register, the company has one shareholder. The registered capital is 6 639 €.
Financial results
Revenue for 2025 was 22 500 €, down 25,0 % on the previous year (30 000 €). Net profit for 2025 was 18 982 € (84,4 % of revenue). The company was profitable in 3 of the 5 reported years. At the end of 2025 the company had total assets of 40 502 € and equity of 38 393 € (equity ratio 94,8 %).
Sources and freshness
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 9. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.